1 active not recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Skin Melanoma: new trials by email Literature Review of Skin Melanoma trials Research Report on Skin Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Encorafenib, Binimetinib, Nivolumab - Melanoma (Skin), Skin Cancer | Early Phase 1 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 14 | 2018-06-14 | 2026-02-05 |
Melanoma (1) · Skin Neoplasms (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Nivolumab (1) · binimetinib (1) · encorafenib (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
United States (1)